Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Aug 26, 2005 by Edgar Snyder

Merck May Consider Settling Some Vioxx Cases


For the tens of thousands who were injured after taking the pain-reliever Vioxx, a settlement without a trial may not be out of the question. As the number of Vioxx-related lawsuits jumps daily, drug manufacturer Merck may consider offering settlements to plaintiffs in specific cases, said the company’s attorneys yesterday.

Merck’s general counsel said they do not plan to offer plaintiffs’ lawyers an overall settlement of Vioxx suits but would consider settling suits brought by people who took Vioxx for long periods of time and had few other risk factors.

Last week a jury ruled against Merck and awarded $253.5 million to a Texas widow who lost her 59-year-old marathon runner husband to a cardiovascular event after taking Vioxx. After the ruling, Merck insisted that they would continue to fight every Vioxx case and would not settle. With more than 5,000 Vioxx cases already filed and cases estimated to reach the 50,000 mark, Merck’s decision is considered a shift in tactical strategy for the drug maker.

For more information about Vioxx, visit our Vioxx Legal Center.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, all drug-related litigation involves co-counsel.

Source: “Maker of Vioxx Says Some Suits May Be Settled.” By Alex Berenson. The New York Times. August 26, 2005.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 30, 2016
September Mocktail: Apple Pie Punch
Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers